RASSE: A new method for structure-based drug design

Journal of Chemical Information and Computer Sciences

Volumn 36, Issue 6, 1996, Pages 1187-1194

  Luo, Zhaowen ^a   Wang, Renxiao ^a   Lai, Luhua ^a  

^a Peking University   (China)

Author keywords

Atom growing; Combinatorial chemistry; Drug design; RASSE; Structure based

Indexed keywords

DIHYDROFOLATE REDUCTASE; ENZYME INHIBITOR; FOLIC ACID ANTAGONIST; LIGAND; PHOSPHOLIPASE A;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER AIDED DESIGN; DRUG ANTAGONISM; DRUG DESIGN; ENZYMOLOGY; ESCHERICHIA COLI; HUMAN; IN VITRO STUDY; METABOLISM;

BINDING SITES; COMPUTER-AIDED DESIGN; DRUG DESIGN; ENZYME INHIBITORS; ESCHERICHIA COLI; FOLIC ACID ANTAGONISTS; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHOSPHOLIPASES A; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 0030277958     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci950277w     Document Type: Article

References (51)

1. Kuntz, I. D. Structure-Based Strategies for Drug Design and Discovery. Science 1992, 257, 1078-1082.
2. Dixon, J. S. Computer-aided drug design: getting the best results. TIBTECH 1992, 10. 357-363.
3. Christophe, L. M. J.; Hol, W. G. J. Structure-based drug design: progress, results and challenges. Structure 1994, 2, 577-587.
4. Greer, J.; Erickson, J. W.; Baldwin, J. J.; Varney, M. D. Application of the Three-Dimensional Structures of Protein Target Molecules in Structure-Based Drug Design. J. Med. Chem. 1994, 37, 1035-1054.
5. Kuntz, I. D.; Meng, E. C.; Shoichet, B. K.; Structure-Based Molecular Design. Acc. Chem. Res. 1994, 27, 117-123.
6. Lybrand, T. P. Ligand-protein docking and rational drug design. Curr. Opin. Struct. Biol. 1995, 5, 224-228.
7. Goodford, P. J. A Computational Procedure for Determining Energetically Favorable Binding Sites on Biologically Important Macromolecules. J. Med. Chem. 1985, 28, 849-857.
8. Boobbyer, D. N. A.; Goodford, P. J.; McWhinnie, P. M.; Wade, R. C. New Hydrogen-Bond Potentials for Use in Determining Energetically Favorable Binding Sites on Molecules of Known Structure. J. Med. Chem. 1989, 32, 1083-1094.
9. Kuntz, I. D.; Blaney, J. M.; Oatley, S. J.; Langridge, R.; Ferrin, T. E. A Geometric Approach to Macromolecule-Ligand Interactions. J. Mol. Biol. 1982, 161, 269-288.
10. DesJarlais, R. L.; Sheridan, R. P.; Seibel, G. L.; Dixon, J. S.; Kuntz, I. D.; Venkataraghavan, R. Using Shape Complementarity as an Initial Screen in Designing Ligands for a Receptor Binding Site of Known Three-Dimensional Structure. J. Med. Chem. 1988, 31, 722-729.
11. Meng, E. C.; Schoichet, B. K.; Kuntz, I. D. Automated Docking with Grid-Based Energy Evaluation. J. Comput. Chem. 1992, 13, 505-524.
12. Sheridan, R. P.; Nilakantan, R.; Rusinko, III, A.; Bauman, N.; Haraki, K. S.; Venkataraghavan, R. 3DSEARCH: A System for Three-Dimensional Substructure Searching, J. Chem. Inf. Comput. Sci. 1989, 29, 255-260.
13. Van Drie, J. H.; Weininger, D.; Martin, Y. C. ALLADIN: an integrated tool for computer-assisted molecular design and pharcophore recognition from geometric, steric and substructure searching of three-dimensional molecular structures. J. Comput.-Aided Mol. Des. 1989, 3, 225-254.
14. Lauri, G.; Bartlett, P. A. CAVEAT: A program to facilitate the design of organic molecules. J. Comput.-Aided Mol. Des 1994, 8, 51-66.
15. Miller, M. D.; Kearsley, S. K.; Underwood, D. J.; Sheridan, R. P. FLOG: A system to select "quasi-flexible" ligands complementary to a receptor of known three-dimensional structure. J. Comput.-Aided Mol. Des. 1994, 8, 153-174.
16. Böhm, H.-J. The computer program LUDI: A new method for the de novo design of enzyme inhibitors. J. Comput.-Aided Mol. Des. 1992, 6, 61-78.
17. Böhm, H.-J. LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. J. Comput.-Aided Mol. Des. 1992, 6, 593-606.
18. Böhm, H.-J. On the use of LUDI to search the Fine Chemicals Directory for ligands of proteins of known three-dimensional structure. J. Comput.-Aided Mol Des. 1994, 8, 623-632.
19. Lawrence, M. C.; Davis, P. C. CLIX: a search algorithm for finding novel ligands capable of binding proteins of known three-dimensional structure. Proteins: Struct. Fund Genet. 1992, 12, 31-41.
20. Ho, C. M. W.; Marshall, G. R. SPLICE: A program to assemble partial query solutions from three-dimensional database into novel ligands. J. Comput-Aided Mol. Des. 1993, 7, 623-647.
21. Rostein, S. H.; Murcko, M. K. GroupBuild: A Fragment-Based Method for De Novo Drug Design. J. Med. Chem. 1993, 36, 1700-1710.
22. Gillet, V.; Johnson, A. P.; Mata, P.; Sike, S.; Williams, P. SPROUT: A program for structure generation. J. Comput-Aided Mol. Des. 1993, 7, 127-153.
23. Gillet, V. J.; Newell, W.; Mata, P.; Myatt, G. J.; Sike, S.; Zsoldos, Z,; Johnson, A. P. SPROUT: Recent Developments in the de Novo Design of Molecules. J. Chem. Inf. Comput. Sci. 1994, 34, 207-217.
24. Mata, P.; Gillet, V. J.; Johnson, A. P.; Lampreia, J.; Myatt, G. J.; Sike, S.; Stebbings, A. L. SPROUT: 3D Structure Generation Using Templates. J. Chem. Inf. Comput. Sci. 1995, 35, 479-493.
25. Leach, A. R.; Kilvington, S. R. Automated molecular design: A new fragment-joining algorithm. J. Comput-Aided Mol. Des. 1994, 8, 283-298.
26. Nishibata, Y.; Itai, A. Automatic Creation of Drug Candidate Structures Based on Receptor Structure: Starting Point for Artificial Lead Generation. Tetrahedron 1991, 47, 8985-8990.
27. Nishibatta, Y.; Itai, A. Confirmation of Usefulness of a Structure Construction Program Based on Three-Dimensional Receptor Structure for Rational Lead Generation. J. Med. Chem. 1993, 36, 2921-2928.
28. Rotstein, S. H.; Murcko, M. A. GenStar: A method for de novo drug design. J Comput.-Aided Mol. Des. 1993, 7, 23-43.
29. Pearlman, D. A.; Murcko, M. A. CONCEPTS: New Dynamic Algorithm for De Novo Drug Suggestion. J. Comput. Chem. 1993, 14, 1184-1193.
30. Ivanov, J.; Karabunarliev, St.; Mekenyan, O. 3DGEN: A System for Exhausive 3D Molecular Design Proceeding from Molecular Topology. J. Chem. Inf. Comput. Scii. 1994, 34, 234-243.
31. Gehlhaar, D. K.; Moerder, K. E.; Kichi, D.; Sherman, C. J.; Ogden, R. C.; Freer, S. T. De Nom Design of Enzyme Inhibitors by Monte Carlo Ligand Generation. J. Med. Chem. 1995, 38, 466-472.
32. Glen, R. C.; Payen, A. W. R. A genetic algorithm for the automated generation of molecules within constraints. J. Comput.-Aided Mol. Des. 1995, 9, 181-202.
33. Roe, D. C.; Kuntz, I. D. BUILDER v.2: Improving the chemistry of a de novo design strategy. J. Comput .-Aided Mol. Des. 1995, 9, 269-282.
34. Clark, D. E.; Frenkel, D.; Levy, S. A.; Li, J.; Murray, C. W.; Robson, B.; Waszkowycz, B.; Westhead, D. R. PRO LIGAND: An approach to de novo molecular design. 1. Application to the design of organic molecules. J. Comput.-Aided Mol. Des. 1995, 9, 13-32.
35. Waszkowycz, B.; Clark, D. E.; Frenkel, D.; Li, J.; Murray, C. W.; Robson, B.; Westhead, D. R. PRO LIGAND: An Approach to de novo Molecular Design. 2. Design of Novel Molecules from Molecular Field Analysis(MFA) Models and Pharmacophores. J. Med. Chem. 1994, 37, 3994-4002.
36. Westhead, D. R.; Clark, D. E.; Frenkel, D.; Li. J.; Murray, C. W.; Robson, B.; Waszkowycz, B. PRO LIGAND: An approach to de novo molecular design. 3. A genetic algorithm for structure refinement. J. Comput.-Aided Mol. Des. 1995, 9, 139-148.
37. Frenkel, D.; Clark, D. E.; Li, J.; Murray, C. W.; Robson, B.; Waszkowycz, B.; Westhead, D. R. PRO LIGAND: An approach to de novo molecular design. 4. Application to the design of peptides. J. Comput.-Aided Mol. Des. 1995, 9, 213-225.
38. Clark, D. E.; Murray, C. W. PRO LIGAND: An approach to de novo molecular design. 5. Tools for the Analysis of Generated Structures. J. Chem. Inf. Comput. Sci. 1995, 35, 914-923.
39. Murray, C. W.; Clark, D. E.; Byrne, D. G. PRO LIGAND: An approach to de novo molecular design. 6. Flexible fitting in the design of peptides. J. Comput.-Aided Mol. Des. 1995, 9, 381-395.
40. Barakat, M. T.; Dean, P. M. The atom assignment problem in automated de novo drug design. 1. Thansferability of molecular fragment properties. J. Comput.-Aided Mol. Des. 1995, 9, 341-350.
41. Barakat, M. T.; Dean, P. M. The atom assignment problem in automated de novo drag design. 2. A method for molecular graph and fragment perception. J. Comput.-Aided Mol. Des. 1995, 9, 351-358.
42. Barakat, M. T.; Dean, P. M. The atom assignment problem in automated de novo drug design. 3. Algorithms for optimization of fragment placement onto 3D molecular graphs. J. Comput.-Aided Mol. Des. 1995, 9, 359-372.
43. Barakat, M. T.; Dean, P. M. The atom assignment problem in automated de novo drug design. 4. Tests for site-directed fragment placement based on molecular complementarity. J. Comput.-Aided Mol. Des. 1995, 9, 448-456.
44. Barakat, M. T.; Dean, P. M. The atom assignment problem in automated de novo drug design. 5. Tests for envelop-directed fragment placement based on molecular similarity, J. Comput.-Aided Mol. Des. 1995, 9, 457-462.
45. Weiner, S. J.; Kollman, P. A.; Case, D. A.; Singh, U. C.; Ghio, C.; Alagona, G.; Profeta, S., Jr.; Weiner, P. A New Force Field for Molecular Mechanical Simulation of Nucleic Acids and Proteins. J. Am. Chem. Soc. 1984, 106, 765-784.
46. Gasteiger, J.; Marsili, M. Iterative partial equalization of orbital electronegativity - A rapid access to atomic charges. Tetrahedron 1980, 36, 3219-3228.
47. Purcel, W. P.; Singer, J. A. A Brief Review and Table of Semiempirical Parameters Used in the Huckel Molecular Orbital Method. J. Chem. Eng. Data 1967, 2, 235-246.
48. Bolin, J. T.; Filman, D. A.; Matthews, D. A.; Hamlin, R. C.; Kraut, J. Crystal Structures of Escherichia coli and Lactobacillus casei Dihydrofolate Reductase Refined at 1.7 Å Resolution. J. Biol. Chem. 1982, 257, 13650-13662.
49. Bernstein, F. C.; Koetzle, T. F.; Williams, G. J. B.; Meyer, M. D., Jr.; Brice, E. F.; Rodgers, J. R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. The Protein Data Bank: A Computer-based Archival File for Macromolecular Structures. J. Mol. Biol. 1977, 112, 535-542.
50. 2 from Inflammatory Exude. Science, 1991, 254, 1007-1010.
51. 2. Science 1990, 250, 1541-1546.